Best Addiction and Substance Abuse Grants in Northern Mariana Islands

Research institutions and eligible organizations in the Northern Mariana Islands can apply for National Institutes of Health SBIRT/P grants to test screening, brief intervention, and referral approaches for alcohol, tobacco, and other drug use in adults experiencing health disparities. Projects must prospectively evaluate SBIRT/P and collaborate with healthcare and community partners; multiple NIH deadlines run through 2027.

The Rural Communities Opioid Response Program - Overdose Response aims to enhance healthcare access in rural areas by addressing urgent needs related to substance use disorder services. This initiative focuses on reducing overdose risks through targeted interventions and support, ensuring that rural communities receive necessary assistance. Funded by the Health Resources and Services Administration, this program is crucial for mitigating the opioid crisis in underserved regions, improving health outcomes, and promoting overall community well-being.

Research institutions and multidisciplinary teams in the Northern Mariana Islands and other U.S. locations can seek NIH funding to develop and test new drugs, devices, and neurostimulation approaches for mental, substance use, and alcohol use disorders. US Dept. of Health & Human Services: National Institutes of Health supports multi-project cooperative programs advancing discovery through proof-of-concept stages.

Research institutions and qualified organizations working on addiction, substance use, alcohol use, or mental health treatment can apply for NIH funding to advance drug, device, and neurostimulation therapies, including in the Northern Mariana Islands. Focused on translational neuroscience and pharmacology, the U01 mechanism supports discrete projects from discovery through preclinical and proof-of-concept stages, with academia–industry partnerships encouraged.

The Rural Communities Opioid Response Program focuses on enhancing behavioral health care services for children and adolescents in rural areas. By providing essential funding, this initiative aims to tackle mental health and substance use disorders, ensuring that young individuals receive the support they need. The program, administered by the Health Resources and Services Administration, is crucial in addressing the unique challenges faced by rural communities, promoting healthier outcomes for future generations.

The Chemical Countermeasures Research Program (CCRP) Initiative aims to support vital research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, including fentanyl and its combinations. This funding opportunity encourages studies that enhance understanding and mitigation strategies for these substances, focusing on both immediate and long-term health impacts. Applications are due by 5:00 PM local time, with optional Letters of Intent accepted 30 days prior to the proposal deadline.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

The Residential Treatment for Pregnant and Postpartum Women program aims to deliver essential services to women facing substance use disorders. By offering comprehensive residential treatment options, the program supports both recovery and the well-being of mothers and their children. Funded by the Substance Abuse and Mental Health Services Administration, this initiative addresses the unique challenges of pregnant and postpartum women, ensuring they receive the care necessary for a successful recovery journey.

The Drug-Free Communities (DFC) Support Program aims to foster collaboration among community coalitions to combat youth substance use. Established by the Drug-Free Communities Act of 1997, it encourages partnerships among various stakeholders, including governmental and non-profit agencies. The program focuses on reducing substance use among youth and promoting protective factors within communities. This funding opportunity is available for those who have completed the initial funding cycle or experienced funding interruptions, supporting their ongoing efforts to create a healthier environment for youth.

The HEAL Initiative aims to combat the opioid crisis through action-oriented research that enhances the translation of addiction epidemiology, prevention, treatment, and recovery services into practice. It prioritizes scalable, evidence-based approaches targeting various levels, including individual and community. The initiative supports a range of methods for research deployment, emphasizing collaboration between researchers and decision-makers to improve outcomes for those affected by addiction and related chronic pain.

The Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use initiative aims to enhance prevention services for infectious diseases among people who use drugs (PWUD). It encompasses two components: a biennial survey to assess service gaps and capacity, and increased support for testing and treatment services. The initiative seeks to improve data utilization in service provision, ultimately increasing testing for HBV, HCV, and HIV, and ensuring more PWUD engage in treatment and care.

The Drug-Free Communities (DFC) Support Program, initiated by the Drug-Free Communities Act of 1997, aims to bolster community coalitions dedicated to preventing youth substance use. Funded by the US HHS's Substance Abuse and Mental Health Services Administration (SAMHSA), this program focuses on collaboration among various stakeholders, including government and non-profit entities, to effectively reduce substance abuse among youth and promote protective factors within communities.

Researchers and research teams in the Northern Mariana Islands studying HIV and substance use can apply for this NIH opportunity, with awards up to US $1,500,000 for high-priority projects. Funding supports basic, clinical, and implementation research that clearly addresses HIV/AIDS among people who use drugs, including addiction and substance use disorders.

Clinician scientists can pursue intensive training in substance use and substance use disorder research through mentored NIH career development funding. This institutional K12 program offers up to US $750,000, emphasizing addiction-focused research and supporting eligible organizations, including those in the Northern Mariana Islands and other U.S. jurisdictions.

The Intervention Research to Improve Native American Health (IRINAH), led by the National Institute on Drug Abuse, focuses on enhancing health outcomes in Native populations. It supports research to identify causes of health issues, develop and test effective interventions, and implement strategies that promote sustainability. Emphasizing community strengths, the initiative aims to rigorously evaluate solutions to reduce health disparities, ensuring interventions can be adapted and shared across diverse communities.

The Rapid Response Opioid and Pain Management ECHO Funding Opportunity by the Association of State and Territorial Health Officials (ASTHO) aims to enhance clinician training in effective pain management strategies. This initiative focuses on non-opioid treatments, substance use screening, and risk reduction counseling, promoting compassionate care while addressing public health challenges and ensuring continuity for patients affected by prescription disruptions. The program seeks to improve overall health outcomes and reduce risks associated with opioid use.

The HEAL Initiative aims to identify new druggable targets for pain within the understudied proteome. This funding opportunity invites applications for pilot projects that generate preliminary data and tools for exploring these targets. The initiative seeks to enhance research on understudied proteins related to pain management, providing essential funding for biochemical and biological work. This NOFO is part of the NIH's broader effort to develop novel medications that address various aspects of opioid addiction and its consequences.

The NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA) aims to renew support for two research consortia focusing on the biological mechanisms of excessive alcohol consumption and Alcohol Use Disorder (AUD). By utilizing advanced technologies and fostering collaboration across multiple sites, this initiative seeks to standardize neurofunctional measures and enhance reproducibility in findings. Investigators are encouraged to prepare for future applications to this NOFO, which will utilize the U24 activity code.

The OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use program aims to provide high-quality mentoring services to youth affected by substance use. This funding opportunity supports various mentoring formats, including one-on-one, group, and peer mentoring, to assist those currently using substances or at risk due to familial influences. The initiative seeks to enhance the well-being of these youth through supportive relationships and guidance.

The OJJDP FY 2026 Opioid Affected Youth Initiative provides funding to support states and localities in combating violent crime and overdose deaths. This initiative aims to enhance prevention, intervention, and treatment strategies for children, youth, and families impacted by substance use disorders. Collaboration among law enforcement, educational institutions, and community organizations is essential to effectively address the needs of at-risk populations and those already involved in the child welfare and justice systems.

The Avant Garde Award supports innovative research on HIV and substance use disorders, encouraging creative scientists to explore high-risk, high-reward approaches. While applications are not currently being accepted, this initiative by the National Institute on Drug Abuse (NIDA) aims to stimulate collaborations and impactful research. Early-stage investigators are particularly encouraged to consider this opportunity as they develop their proposals for future funding. The program uses the DP1 activity code, fostering transformative advancements in biomedical and behavioral science.

The HEAL Initiative aims to address the complex interplay between chronic pain and opioid use disorder (OUD), affecting 40-60% of OUD patients. Through the IMPOWR initiative, this funding opportunity seeks to develop integrated care strategies that enhance treatment delivery at health systems levels. By identifying effective interventions and collaborative care models, the initiative strives to improve patient outcomes in managing both chronic pain and OUD, while emphasizing the roles of various healthcare professionals in this integrated approach.

The BJA FY 2026 Residential Substance Abuse Treatment for State Prisoners Formula Grants Program aims to enhance the capacity of state, local, and tribal governments in providing residential substance use disorder treatment for incarcerated individuals. This funding opportunity supports evidence-based treatment, aids in reintegration into society, and promotes continuity of care through community-based recovery services, ultimately improving outcomes for those with substance use and co-occurring mental health disorders.

The OJJDP FY 2026 Expanding Youth Access to Community-Based Treatment program aims to enhance support for youth facing substance use and mental health challenges. This funding opportunity focuses on community-based treatment initiatives that cater to youths with substance use disorders (SUD) and co-occurring mental health conditions. By fostering cross-system strategies, the program seeks to improve outcomes for at-risk youth and reduce recidivism through better access to necessary treatment services.

The OJJDP FY 2026 Family Treatment Court Program aims to support state and local courts, as well as Tribal governments, in establishing or enhancing family treatment courts. These courts are designed to provide substance use treatment and other supportive services for parents involved with the child welfare system due to issues like child abuse or neglect. By focusing on intensive judicial monitoring and interventions, the program seeks to improve outcomes for children, parents, and families affected by substance use disorders.

The HEAL Initiative aims to address the significant overlap between chronic pain (CP) and opioid use disorder (OUD), with 40-75% of individuals affected by both. The IMPOWR project focuses on testing innovative interventions and implementation strategies to integrate care for CP and OUD across various health systems. The BEACON Center will enhance network coordination, build capacity, and develop resources to address barriers in service delivery, ultimately improving sustainability and scalability of evidence-based practices.